Kite Pharma, Inc. Operating Expenses
Kite Pharma, Inc. reported Operating Expenses of $111.97 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2017-08-08
- Kite Pharma, Inc. operating expenses for the quarter ending 2017-06-30 was $111.97M, a 57.55% increase year-over-year.
- Kite Pharma, Inc. operating expenses for the quarter ending 2017-03-31 was $101.75M, a 99.13% increase year-over-year.
- Kite Pharma, Inc. operating expenses for the quarter ending 2016-12-31 was $90.70M, a 110.40% increase year-over-year.
- Kite Pharma, Inc. operating expenses for the quarter ending 2016-09-30 was $82.49M, a 149.57% increase year-over-year.
- Kite Pharma, Inc. operating expenses for fiscal 2016 was $295.36M, a 143.68% increase from fiscal 2015.
- Kite Pharma, Inc. operating expenses for fiscal 2015 was $121.21M, a 230.65% increase from fiscal 2014.
- Kite Pharma, Inc. operating expenses for fiscal 2014 was $36.66M, a 470.37% increase from fiscal 2013.
- Kite Pharma, Inc. operating expenses for fiscal 2013 was $6.43M, a 149.01% increase from fiscal 2012.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | $111.97M 10-Q · filed 2017-08-08 | $213.24M 10-Q · filed 2017-08-08 | $304.42M derived: sum of 3 quarters · filed 2017-08-08 | $386.91M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2017-03-31 | $101.75M 10-Q · filed 2017-05-08 | $192.45M derived: sum of 2 quarters · filed 2017-05-08 | $274.94M derived: sum of 3 quarters · filed 2017-05-08 | $346.01M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-12-31 | $90.70M 10-K · filed 2017-02-28 | $173.19M derived: sum of 2 quarters · filed 2017-02-28 | $244.26M derived: sum of 3 quarters · filed 2017-08-08 | $295.36M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $82.49M 10-K · filed 2017-02-28 | $82.29M 10-Q · filed 2016-11-09 | $153.56M derived: sum of 2 quarters · filed 2017-08-08 | $204.08M 10-Q · filed 2016-11-09 | $247.76M derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-06-30 | $71.07M 10-Q · filed 2017-08-08 | $70.88M 10-Q · filed 2016-08-08 | $122.17M 10-Q · filed 2017-08-08 | $121.78M 10-Q · filed 2016-08-08 | $165.28M derived: sum of 3 quarters · filed 2017-08-08 | $198.33M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $51.10M 10-Q · filed 2017-05-08 | $50.91M 10-Q · filed 2016-05-09 | $94.21M derived: sum of 2 quarters · filed 2017-05-08 | $127.26M derived: sum of 3 quarters · filed 2017-05-08 | $153.81M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | $43.11M 10-K · filed 2017-02-28 | $42.92M 10-K · filed 2016-02-29 | $76.16M derived: sum of 2 quarters · filed 2017-02-28 | $102.71M derived: sum of 3 quarters · filed 2017-02-28 | $121.21M 10-K · filed 2017-02-28 | $120.58M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $33.05M 10-K · filed 2017-02-28 | $32.86M 10-Q · filed 2015-11-12 | $59.60M derived: sum of 2 quarters · filed 2017-02-28 | $77.66M 10-Q · filed 2016-11-09 | $91.35M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $26.55M 10-K · filed 2017-02-28 | $26.36M 10-Q · filed 2015-08-10 | $44.79M 10-Q · filed 2016-08-08 | $58.30M derived: sum of 3 quarters · filed 2017-02-28 | $67.40M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $18.50M 10-K · filed 2017-02-28 | $18.43M 10-Q · filed 2015-05-15 | $31.75M derived: sum of 2 quarters · filed 2017-02-28 | $40.85M derived: sum of 3 quarters · filed 2017-02-28 | $51.99M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $13.26M 10-K · filed 2016-02-29 | $22.36M derived: sum of 2 quarters · filed 2016-02-29 | $33.50M derived: sum of 3 quarters · filed 2016-02-29 | $36.66M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $9.10M 10-K · filed 2016-02-29 | $20.24M derived: sum of 2 quarters · filed 2016-02-29 | $23.40M 10-Q · filed 2015-11-12 | $25.80M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $11.14M 10-K · filed 2016-02-29 | $14.30M 10-Q · filed 2015-08-10 | $16.70M derived: sum of 3 quarters · filed 2016-02-29 | $18.21M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $3.16M 10-K · filed 2016-02-29 | $5.56M derived: sum of 2 quarters · filed 2016-02-29 | $7.07M derived: sum of 3 quarters · filed 2016-02-29 | $8.50M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $2.40M 10-K · filed 2015-03-26 | $3.90M derived: sum of 2 quarters · filed 2015-03-26 | $5.34M derived: sum of 3 quarters · filed 2015-03-26 | $6.43M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $1.51M 10-K · filed 2015-03-26 | $2.94M derived: sum of 2 quarters · filed 2015-03-26 | $4.03M 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $1.43M 10-K · filed 2015-03-26 | $2.52M 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | $1.09M 10-K · filed 2015-03-26 | ||||||
| 2012-12-31 | $2.58M 10-K · filed 2015-03-26 |